Results for tag: "Cetuximab"

Cetuximab is a monoclonal antibody used in the treatment of lung cancer. It is used in combination with chemotherapy to treat non-small cell lung cancer (NSCLC). Cetuximab works by targeting the epidermal growth factor receptor (EGFR), which is found on the surface of some cancer cells. This helps to slow down or stop the growth of cancer cells. Cetuximab is approved by the US Food and Drug Administration (FDA) for the treatment of NSCLC in combination with chemotherapy. It is also approved for the treatment of metastatic colorectal cancer. Cetuximab is available in both intravenous and subcutaneous formulations. It is typically administered in combination with chemotherapy drugs such as cisplatin, carboplatin, and paclitaxel. Common side effects of cetuximab include skin rash, fatigue, nausea, and diarrhea. Some companies in the Cetuximab market include Merck & Co., Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, and F. Hoffmann-La Roche Ltd. Show Less Read more